A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies. Bruxelle JF, Kirilenko T, Trattnig N, Yang Y, Cattin M, Kosma P, Pantophlet R.  Sci Rep. 2021 Feb 25;11(1):4637.

HIV-1 entry and prospects for protecting against infection. Bruxelle JF, Trattnig N, Mureithi MW, Landais E, Pantophlet R. Microorganisms. 2021 Jan 22;9(2):228. doi: 10.3390/microorganisms9020228.


Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies. Bruxelle JF, Kirilenko T, Qureshi Q, Lu N, Trattnig N, Kosma P, Pantophlet R. Sci Rep. 2020 May 5;10(1):7582. doi: 10.1038/s41598-020-64500-8.